Cipla expanded its consumer healthcare portfolio by entering into definitive agreements to acquire a one hundred percent equity stake in Inzpera Healthsciences Private Limited. This strategic corporate acquisition positions Inzpera Healthsciences as a wholly owned subsidiary of Cipla, integrating its specialized product offerings in pediatric nutrition, gut health, and lifestyle wellness. The transaction is designed to accelerate Cipla's growth within the over-the-counter and preventive health segments, bridging the gap between prescription pharmaceuticals and consumer-driven wellness solutions through targeted brand integrations and expanded market distribution channels.